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LEARNING OBJECTIVES
1. Understanding that the optic tract can be regenerated
and that this process is dynamic.
2. How nanotechnology is beginning to impact medicine
and the eye.
3. Size changes ADME and can also impact toxicity. 
CME QUESTIONS
1. How does size change the properties of drugs and
materials?
2. How does time impact the ability to regenerate the
optic tract and nerve?
3. How would this type of material change the delivery,
targeting, and dose regime of a treatment? 
KEYWORDS
1. Self-assembled systems
2. CNS regeneration
3. Nanotechnology
4. fMRI
5. Vision
INTRODUCTION
Within the emerging field of stem cells there is a need for
an environment that can regulate cell activity, to slow
down differentiation or proliferation, in vitro or in vivo
while remaining invisible to the immune system.
The ability to keep the cells forever young during
implantation is very important to the reconstitution of
tissue or organs being replaced. In the emerging field of
stem cells there is a need for an environment that can be
tuned to the needs of the cells to slow down the
differentiation or proliferation in vitro or in vivo while
remaining invisible to the immune system. We have shown
that when cells are placed into a defined system we can
delay their proliferation, differentiation and maturation
depending on the density of the cell population, density of
the matrix, and the local environment. This is done in a
three dimensional environment that allows the benefits of
cell therapy to be more fully realized.
Each time in history where there is a power of 10 increase
in resolution it is followed by an exponential increase in
the number of discoveries1. We are now sitting at that
threshold, with the dawning of nanotechnology and our
ability to manipulate molecules in the body and build
nanodevices. These devices will allow for a higher
resolution of analysis. This symposium is to outline 
what is fact today and where things are going in the 
near future.
Nanotechnology is often associated with materials
fabrication, microelectronics, and microfluidics. Until now,
the use of nanotechnology and molecular self assembly in
biomedicine to repair injured brain structures has not
been explored. In order to achieve axonal regeneration
after injury in the central nervous system several
formidable barriers must be overcome, such as scar tissue
formation after tissue injury; gaps in nervous tissue
formed during phagocytosis of dying cells after injury and
the failure of many adult neurons to initiate axonal
extension2. 
Using the mammalian visual system as a model, we
previously demonstrated that a designed self-assembling
peptide nanofiber scaffold creates a permissive
environment not only for axons to regenerate through the
site of an acute injury, but also to knit the brain tissue
together. In experiments using a severed optic tract in the
hamster, we showed that regenerated axons were able to
reconnect to target tissues with sufficient density to
promote functional return of vision, as evidenced by
visually elicited orienting behavior. The peptide nanofiber
scaffold not only represents a new nanobiomedical
technology for tissue repair and restoration, but also
raises the possibility of effective treatment of central
nervous system and other tissue or organ trauma2. 
There are four distinct issues that need to be addressed in
order for successful central nervous system (CNS)
regeneration to occur3 (Figure 1): 
1. Preserve - How can neurons with damaged axons be
kept alive long enough to regrow and obtain functional
regeneration? 
2. Permit - How can a permissive environment be
created that will allow axons to grow through the site
of the lesion? 
Using the mammalian visual system as a model, we
showed that a designed self-assembling peptide
nanofiber scaffold (SAP), in combination with
Chondroitenase-ABC creates a permissive environment
not only for axons to regenerate through the site of an
acute injury, but also to knit the brain tissue together
in both young and adult animals.
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3. Promote - How can axon growth be promoted in the
correct direction coincident with the onset of the
permissive environment?
The combination of SAP and CNTF is shown to offer an
effective new means of creating a permissive
environment for axonal growth while CNTF promotes
growth of axons across this environment in tissue
disruptions caused by traumatic injury to the CNS,
allowing regrowth of axons into the SC and functional
return of vision.
4. Plasticity - How can changes in morphology in vivo be
promoted so the axon connections are functional in
the target, mapped correctly and are in sufficient
amount to drive behavior?
First P: preserving the cell
Until recently, the area of cell preservation was the most
important area of CNS regeneration, because without the
living cell, neuron regeneration is impossible. Treatments
are available, such as hypothermia, which can keep CNS
tissue alive or delay apoptosis but can only be used in the
surgical theater.
Nanotechnology can keep cells alive6 either through (1)
enabling better delivery of a small molecule, such as
methylprednisone, (2) transfections using a known viral
delivery method with a nanocomplex, or (3) the promise
of RNA-mediated interference (RNAi) technology that will
impact the future of this field. Each treatment is new, or
has better-enabled control and delivery, because of
nanotechnology3. 
Second P: creating a permissive environment
Several formidable barriers must be overcome to achieve
axonal regeneration after injury in the CNS. These
obstacles are (1) scar tissue formation after tissue injury,
(2) gaps in nervous tissue formed during phagocytosis of
dying cells after injury, (3) factors that inhibit axon growth
in the mature mammalian CNS, and (4) failure of many
adult neurons to initiate axonal extension. 
Through reducing or overcoming the first two and
possibly the first three of the barriers described above and
creating a permissive environment for axonal regrowth
using a synthetic biologic nanomaterial, with components
that break down into beneficial building blocks and
produce no adverse effects in the CNS, functional
behavioral recovery becomes a reality.
Three avenues are available through which a permissive
environment can be created: (1) blockade of scar
formation; (2) removal of the scar and accompanying
growth inhibitory signals, and (3) use of bridge materials
that are grafts or artificial self-assembling peptides.
The inactivation of inhibitory signals in the scar creates a
local permissive environment at the site of injury.
However, the permissive environment is not limited to the
scar and the area surrounding the injury, but extends to
the target-tissue inhibitory factors, such as ephrins and
Eph receptors, that block or cause axon growth cone
collapse. In the past, regeneration was the removal of
barriers to axon growth.
Neurons that are normally able to grow may not be able to
grow through an injury, depending on the conditions in
the local environment of the injury site. The goal is to
attack the local environment in a way that will permit
neurons to grow through to the target tissue. If the path is
not permissive, neurons will stop growing and produce
retraction bulbs and a cavity3.
Third P: promoting neuronal growth
Once a permissive environment has been created, the next
task is to restore the CNS neuronís ability to elongate and
promote growth. This difficult problem has two
components that must be addressed in a temporally
distinct manner. The ëëclock needs to be turned backíí on
the neuron and reset to early development, which means
turning down transmission and turning up elongation
while ensuring that the environment through which the
neurons must grow is permissive.
FIGURE 1. Each of the four Pís of regeneration is represented
by horizontal bars depicting the time of treatment and the
duration the treatment must remain active. P1 is preserving
cells and is broken down into two parts: the anti-apoptosis and
anti-necrosis treatment and the growth factor support during
elongation. P2 is also broken into two parts: the first treatment
is to create a permissive environment around the site of injury;
then the target tissue must be made permissive to the
reinnervating axons. P3 is the promotion of growth of the axons
in an elongation mode. P4, plasticity, has two parts: the
immediate post-injury plasticity must be reduced so filling-in is
minimal and, while axons are reconnecting in the target tissue,
plasticity must be up-regulated. This function can be
accomplished by factors or training. Timeline runs from left to
right and starts at the time of injury. A is the time of injury, B is
24-hours post injury, C is 72 to 96 hours post injury, D is 2
weeks to 4 months and can extend longer, and E is years.
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Previously, regeneration was simply the removal of the
inhibitory signals, but this has proven to be inadequate to
achieve functional recovery in the CNS. Early in
development, during the elongation phase of growth,
many CNS neurons are able to grow through a permissive
environment without any promotion. However, after early
development this ability seems to be lost. The assumption
is that neurons are successfully preserved and a
permissive environment has been created.
Two distinct issues must be addressed in promoting axon
growth: 1) getting the axons to elongate in a similar way
to the early stage of development and 2) getting the signal
for growth to switch from elongation to arborisation when
the target tissue is reached.
Promotion of growth for regeneration is a relatively new
area. Until recently the dominant theme in regeneration
was removing the scar or inhibitory molecules, which
experts believed would cause regeneration to
spontaneously occur. This misconception was caused by
the inability to overcome the inhibitory environment at the
site of CNS injury and the ëëaspiriníí approach to
regeneration: one magic bullet will cure the deficit. 
There was also a lack of understanding that neurons are
not always able to grow.
For clarification purposes, grow or growth refers to the
ability of the axons to elongate or extend collaterals
several microns to millimeters. Arborize, focalize, or
prune refers to the ability of dendrites to make new,
strengthen, or eliminate existing connections. Promotion
means the elongation of axons over long distances.
The promotion of axon growth in the adult CNS has no
magic bullet. The careful selection of treatments to
achieve axon growth promotion in the population of
injured axons desired requires understanding early
development of each neuronal type and the surrounding
environment, in addition to the distances each axon must
grow before arborization commences.
The discovery of a non-viral transfection technique, along
with the successful transfection of Bcl-2 in vivo at
promising rates in a targeted neuronal population, is the
first step toward successfully targeting an affected
neuronal population with a growth-promoting gene.
Finally, controlling neurons as they regenerate in the CNS
requires new ways to pull apart the contribution of
different aspects of growth promotion3. The fourth, and
possibly the most important aspect of regeneration and
recovery of function, is plasticity.
Fourth P: plasticity
Plasticity comes into play two times after injury. First,
during the immediate period after an injury, sprouting
occurs by the surrounding tissue, occupying the vacated
space. Second, plasticity, driven by behavior, occurs after
reinnervation. Although these two plastic events are
equally important in CNS regeneration, this article only
addresses plasticity after reconnection to the target
tissue. More plasticity is the growth of terminal arbors or
the growth of interneurons over very short distances. 
A few microns would be the longest neurite or dendrite
change, which can also mean the up-regulation of
transmission at an existing synapse; however, although
this fits the definition of plasticity, this measurement was
not possible until a couple of years ago in vivo.
The four Pís framework outlines the issues that must be
addressed before behavioral return of function can occur.
With the advent of nanomedicine, functional return after
trauma or stroke seems to be an achievable medical goal,
and not the intractable problem it once was.
Nanomedicine is an area where size really does matter.
People are often amazed at how small things can make
such a big impact, and this is also true in nanomedicine.
Experts always believed that to get therapeutically relevant
dosages, blood serum levels needed to be checked.
However, in the realm of nanomedicine, the only relevant
measures are how to impact the specific cell population,
how long to continue, and how to measure it
noninvasively3.
NANOSCAFFOLDS
Scaffolds play a central role in organ regeneration. 
They act as a template and guide for cell proliferation, 
cell differentiation and tissue growth, as well as a way to
control the release of drugs at rates matching the
physiological need of the tissue. The surface of the
scaffold provides a substrate for cell adhesion and
migration, which can influence the survival of 
transplanted cells or the invasion of cells from the
surrounding tissue4. 
Although many promising strategies have been 
developed for controlling the release of drugs from
scaffolds, there are still challenges to be addressed for
these scaffolds to serve as successful treatments: 
(a) precise placement of the cells into the scaffold to
prevent migration from the scaffold before it has been
repopulated; (b) ability of the scaffold to allow cells to
migrate into it, in order to reconstitute the tissue from 
the surrounding area and (c) prevention of the acidic
breakdown of the cell scaffold, which results in an 
adverse environment for cell growth4. 
Many types of scaffolds, utilizing a wide range of
materials, have been used for the regeneration and repair
of the nervous system. In treating TBI or SCI drug
delivering scaffolds may need to be combined with cell
transplantation to obtain functional recovery4. 
TYPES OF NANOSCAFFOLDS
Natural materials can impart intrinsic signals within the
structure that can enhance tissue formation. They include
alginate, chitosan, collagen, fibrin and hyaluron. They
possess many properties that make them attractive for
tissue applications. Many of these materials contain sites
for cell adhesion, allowing for cell attachment. These
materials also exhibit similar properties to the tissues they
are replacing. Since these materials are obtained from
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natural sources, they must be purified to ensure that no
foreign body response occurs after implantation.
Homogeneity of product between lots can be an issue with
natural materials. 
In addition: (a) chitosan can cause an allergic reaction; 
(b) fibrin, from blood products, and collagen, from animal
products, have been known to cause an immune response;
(c) some, but not all, natural materials allow for cell
infiltration; (d) the modulus of these materials may be very
different from that of the tissue they are implanted in. In a
pulsatile environment the materials will shear away from
the surrounding tissue, causing additional damage; and
(e) by creating an environment that will not move in the
same way as the surrounding tissues, the cells are
subjected to an environment different from their native
one; this can lead to a very different expression pattern of
genes, one that produces an extracellular environment
that is not conducive to repair, possibly leading to the
development of tissue unable to function like the original
tissue4.
Synthetic materials have known compositions and can be
custom designed with specific properties. They include
PEG, PLA/PGA/PLGA acid and pHEMA-MMA. PLAs, PLGAs
and MMAs have recently been used to form scaffolds pre-
impregnated with cells; the entire scaffold is then
implanted in the damaged tissue area. Synthetic materials
have many advantages for use as scaffolds. These
polymers can be tailored to produce a wide range of
mechanical properties and degradation rates. They also
have known compositions and can be designed to
minimize the immune response. Finally, synthetic
polymers can be reacted together to combine the
properties that are unique to each. A drawback is that
degradation by-products can be absorbed by the body
and may cause pH changes around the implantation site,
leading to necrosis and delayed apoptosis4. 
The next generation of cell scaffolds to emerge are
synthetic biological materials, or designed self-
assembling peptides, that spontaneously form nanofibers
creating a scaffold-like tissue-bridging structure that
provides a framework for axonal regeneration. They are
formed through the assembly of ionic self-complementary
peptides and are designed by using alternating positive
and negative L-amino acids that form highly hydrated
scaffolds in the presence of physiological-concentration
salts, i.e., saline, tissue culture media, physiological
solutions, or human body fluids such as cerebrospinal
fluid. Because these scaffolds assemble using weak ionic
bonds and van der Waalís forces the scaffolds are motile
and able to disassemble and reassemble in the
nanodomain, depending on the charge change4. 
They allow for high cell implantation densities and enables
cells to migrate freely in and out of the scaffold and the
surrounding tissue. The material can also be designed to
match the modulus of the surrounding tissue. There
appears to be no immune response when the material is
either (a) pre-buffered or (b) allows buffering by the
surrounding tissue and liquid in the injury site. During
breakdown there is no decrease of pH in the local
environment. A drawback is that making pure
nanomaterials in large quantities can be difficult because
the process involves putting molecules together one at a
time. To do that with high fidelity, in bulk, is a
technological challenge4. 
EXPERIMENT: CREATING A MORE 
PERMISSIVE ENVIRONMENT
Behavioral testing of animals drives plasticity and rewiring
of the brain in the superior colliculus. Neurons in the adult
mammalian (CNS) have limited capability to regenerate
their axons after injury. It is generally accepted that the
lower capacity of CNS axons to regenerate is partly due to
the local environment of the injured CNS axons. Traumatic
injury in CNS is often followed by robust glial reaction, the
failure of CNS axons to regenerate is partly attributed to
the inhibitory surface of the glial scar and extracellular
matrix (ECM) produced by oligodendrocyte and astrocyte.
The glycosaminoglycan side chains of proteoglycans, such
as chondroitin sulfate (CS) are putative components of the
ECM contributing to the non-permissive properties of the
injured CNS. Furthermore, a tissue gap formed after
traumatic injury would completely block the 
re-innervation of the CNS axons.
In this experiment, the brachium of the superior colliculus
was completely transected in a group of 22 adult golden
hamsters and 20 l of 1% Self-Assembling Peptide (SAP)
and/or 2.5 units/ml (final concentration) Chondroitinase
ABC were injected into the lesion site. The progression of
axonal regeneration and the re-innervations of the
superior colliculus were monitored at 4, 6, and 12weeks
following the lesion by intravitreal injection of CTB-FITC.
We found that SAP nanofiber scaffold used in combination
of Chondrointinase ABC could facilitate the retinal fibers
to regenerate across the lesion site. The re-innervations
of the superior colliculus were observed in the
combination group as early as four weeks after the
transection while controls showed no reinnervation at any
time point. In behavioral study, the adult hamsters
showed a functional return of vision in the
SAP/Chondroitinase ABC treated cases beginning at 6
weeks post surgery sooner than those treated with either
SAP or Chondroitinase ABC alone. Thus, the
SAP/Chondroitinase ABC combination is shown to offer an
effective new means of creating a more permissive
environment for growth after traumatic injury to the CNS,
allowing regrowth of axons into the denervated site5.
EXPERIMENT: IMAGING REGENERATION
A tissue gap caused by deep transections of the optic tract
(OT) in the midbrain can completely block the re-
innervation of the superior colliculus (SC) by the retina,
even when done at young ages when the axons have
regenerative potential. Previously we demonstrated that
the SAP facilitated the reconstruction of a tissue substrate
that supports regeneration across the tissue disruption,
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even if treated 3 months after the original lesion. We
showed that by using a nano contrast agent (NCA) optic
tract regeneration can be visualized in vivo in a
mammalian chronic injury model.
In a group of young adult hamsters (8 wk), the OT at the
brachium of the SC was completely severed with a deep
knife wound, extending 1-2 mm below the surface from
the midline to a point beyond the lateral margin of SC.
Following the transection of the optic tract at the
brachium of the SC, the eyes were injected with a NCA and
imaged in a 7 Tesla fMRI. This was repeated 3 more times
just before the second surgery and SAPNS treatment, then
twice following the treatment. During the second OT
surgery the animals had a partial scar resection and were
injected with 100 l of 1% SAPNS into the site of injury.
The contralateral side of the same animal served as the
control. Imaging revealed that the first transection was
complete. Imaging after the second treatment revealed
regenerated axons in the SC of the SAPNS-treated
animals. A 7 Tesla fMRI is able to detect axons in the optic
tract in hamsters before, during and after regeneration in
a chronic injury treatment model6. 
EXPERIMENT: PLACING CELLS INTO A DEFINED 
3-DIMENSIONAL ENVIRONMENT
Here we show the importance of placing cells into a
defined system within a 3-dimensional (3D) environment,
allowing better control over growth and differentiation in
order to effectively mimic the extracellular matrix both in
vitro and in vivo. 
This paper will discuss: (a) the appropriate concentration
of material based on the type of cells being implanted; (b)
determining if the material needs to be pre-buffered, or if
the cells need to be pre-cultured in the material before it
is then injected into the lesion area; (c) controlling the
physical environment to make it more permissive for cell
migration while at the same time slowing, or even
arresting, the proliferation, elongation, and differentiation
of the implanted cells; and (d) modulation of the immune
system with a unique physical environment around the
implant site4. 
Within the emerging field of stem cells there is a need for
an environment that can regulate cell activity, to slow
down differentiation or proliferation, in vitro or in vivo
while remaining invisible to the immune system. By
creating a nano environment surrounding PC12 cells,
Schwann cells and neural precursor cells (NPCs), we were
able to control the proliferation, elongation,
differentiation and maturation in vitro. We extended the
method, using SAP, to living animals with implants in the
brain and spinal cord. Here we show that when cells are
placed in a defined system we can delay their
proliferation, differentiation and maturation depending on
the density of the cell population, density of the matrix,
and the local environment. A combination of SAP and
young cells can be implanted into the CNS, eliminating the
need for immuno-suppressants4. 
SUMMARY
The ability to keep the cells forever young during
implantation is very important to the reconstitution of
tissue or organs being replaced. In the emerging field of
stem cells there is a need for an environment that can be
tuned to the needs of the cells to slow down the
differentiation or proliferation in vitro or in vivo while
remaining invisible to the immune system. We have shown
that when cells are placed into a defined system we can
delay their proliferation, differentiation and maturation
depending on the density of the cell population, density of
the matrix, and the local environment. This is done in a
three dimensional environment that allows the benefits of
cell therapy to be more fully realized.
CME ANSWERS
1. The optic tract can be regenerated in the brain and
there is evidence that the optic nerve can be
regenerated in mammals.
2. Time from injury to treatment will determine the type
of treatment that is needed. If there is an extended
time from injury to treatment, a scar will form and
decrease the number and ability of axons to
regenerate. The scar will have to be removed and the
axon stimulated to grow before they can reconnect.
3. The material can create an environment that mimics
early development, allowing cells to migrate and
regrow.
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